Resp Flashcards
Management of haemodynamically stable PE
apixaban/rivaroxaban immediately if Well’s >4
Stable: DOAC for 3m/6m based on unprovoked/provoked
PESI score +/- Echo for Right Heart Strain
Consider IVC filter if CI to thrombolysis
Management of unstable PE
no CI to thrombolysis: unfractionated heparin
then hold heparin while administering alteplase
then heparin
CI to thrombolysis: heparin then surgery
Management of primary pneumothorax
<2cm: review in 2-4w
>2cm or SOB: aspirate
Management of secondary pneumothorax
<1cm: admit for 24h and O2
1-2cm: aspirate
>2cm: chest drain
Tension pneumothorax management
14-16G needle 5th ICS MAL
Management acute COPD
aim sats 88-92% (ABG again within 1h starting O2)
Start 28% O2 (or 24% if available) Neb salbutamol 5mg b2b Ipratropium 0.5mg every 4h Pred PO 30mg Co-amoxiclav/amox/clari/doxy
Consider aminophylline, ITU, NIV
Indications for BIPAP
COPD with resp acidosis 7.25-7.35
T2RF secondary to MND, deformity or OSA
Cardiogenic pulmonary oedema unresponsive to CPAP
Management of chronic COPD
Conservative: vaccines, smoking cessation, pulmonary rehab
Inhalers based on symptoms and risk (mMRC and GOLD system)
mucolytics
rescue packs
?Long term oxygen therapy if pO2 <7.2 or <8 and signs of decompensation (secondary polycythaemia, peripheral oedema, pulmonary HTN)
consider surgery: lung volume reduction, bullectomy, transplant
COPD inhaler management
1) SABA OR SAMA for breathlessness
2a) If NO asthmatic features: LABA + LAMA
2b) if ASTHMATIC features: LABA + ICS
3) LABA + LAMA + ICS
What is SABA/SAMA/LAMA/LABA/Symbicort/LTRA
SABA: salbutamol SAMA: ipratropium LABA: salmeterol LAMA: tiotropium symbicort: LABA + ICS LTRA: montelukast
Chronic Asthma management
Conservative: Review technique, avoid triggers, monitor peak flow, asthma action plan, flu vaccine
1) SABA + ICS
2) add LABA
3) Add LTRA or increase ICS
discard LABA if not working
4) Refer to specialist
FEV1 actual vs predicted COPD categories
>80% = mild 50-79% = moderate 30-49 = severe <30% = very severe
Acute Asthma management
High flow O2
Nebuliser (5mg salbutamol b2b + ipratropium every 4h)
pred PO OR hydrocort if can’t tolerate
Magnesium sulfate IV + senior support
Further support: aminophylline, ITU, intubation
Acute asthma PEF categories
50-75%: moderate
33-50%: acute severe
<33%: life threatening
normal/raised pCO2 = near-fatal
management for allergic bronchopulmonary aspergillosis
oral prednisolone
itraconazole 2nd line
consider antibiotics
salbutamol
3 forms of bronchiectasis
cylindrical
cystic
varicose
Management of bronchiectasis
Conservative: airway clearance techniques, flutter device
medical: mucolytics, prophylactic Abx, consider itraconazole
LABA/ICS
Surgery for severe disease/localised disease
Management of CF
conservative: physio, airway clearance techniques
pancreatic replacement therapy
high calorie diet
Medical: nebulised mucolytics, SABA/LABA, long term antibiotics (fluclox) with additional rescue antibiotics
nebulised hypertonic saline
laxatives
USDA
Surgical: Lung/liver transplant
Management of fibrosis
stop fibrosis drug
rehab
support groups
pirfenidone
LTOT if pO2 <7.3 OR 7.3-8 AND (polycythaemia, hypoxaemia, peripheral oedema or pul HTN)
steroids (poor evidence)
Treat any post nasal drip with steroids
Treat any GORD
transplant
management of sarcoid
NSAIDs
high dose steroids if parenchymal lung disease, uveitis, hypercalcaemia, neuro/cardio
consider other immunosuppression (methotrexate, ciclosporin)
Squamous Cell Carcinoma endo link
high calcium due to PTHrP
TSH hyperthyroidism